Nephritogenoside is a glycopeptide with the ability to induce chronic progressive glomerulonephritis (end stage kidney) in homologous animals, by a single footpad injection. This substance contains a novel carbohydrate-peptide linkage, Le. the trisaccharide (3 glucose residues) chain is a-N-glycosidically linked to the polypeptide chain through the amido nitrogen of an asparagine residue at the N-terminal. It was found that the peptide portion of nephritogenoside is composed of twenty-one amino acids (Asnl-Pro-Leu-Phe-Gly6-IleAla-Gly-Glu-Asp'o-G1y-Pro-Thr-Gly-Pro'6-Ser-GlyIle-Val-Gly20-Gln21) and that the peptide portion has a repeated Gly-X-Y structure.
Nephritogenoside is a glycopeptide with the ability to induce chronic progressive glomerulonephritis (end stage kidney) in homologous animals, by a single footpad injection. This substance contains a novel carbohydrate-peptide linkage, Le. the trisaccharide (3 glucose residues) chain is a-N-glycosidically linked to the polypeptide chain through the amido nitrogen of an asparagine residue at the N-terminal. It was found that the peptide portion of nephritogenoside is composed of twenty-one amino acids (Asnl-Pro-Leu-Phe-Gly6-IleAla-Gly-Glu-Asp'o-G1y-Pro-Thr-Gly-Pro'6-Ser-GlyIle-Val-Gly20-Gln21) and that the peptide portion has a repeated Gly-X-Y structure.
Nephritogenoside is a glycopeptide isolated as a minor component in the basement membrane of normal animals (1). This substance was designated nephritogenoside because it is a glycoside with the ability to induce glomerulonephritis in homologous animals (2) . This finding has been confirmed by Nishii et al. (3). However, isolation and purification of this compound has, in general, been very difficult, because only 5-6 mg of nephritogenoside is isolated and purified from the perfused renal cortices of 1200 normal rats, after a preparation period lasting more than 3 months. Thus, the report of Nishii (3) may be the one with a scarcity value.
We have demonstrated that the biologically active portion of nephritogenoside is in the sugar moiety and that the receptor for concanavalin A present in normal rat glomerular basement membranes can be identified as nephritogenoside, which is located in the inner layer (lamina rara interna) of the glomerular capillary loop (1) .
From methylation analysis (4), the concanavalin A test (l), and studies of I3C NMR data (5, 21), in 1980, we proposed the following structure for nephritogenoside: Glc(a1 + 6) Glc(P1-6)Glc(al+ N)-peptide.
The peptide portion of nephritogenoside is directly and a-N-glycosidically bonded to the trisaccharide portion (4, 5, 21) . The proposed structure was supported by the successful production of synthetic compounds with nephritogenic activity (6, 7) .
However, it has long been difficult to determine the amino acid sequence of nephritogenoside and site of carbohydrate attachment in the glycopeptide. We have recently found the reason for this difficulty, based on evidence that the carbohydrate chain of nephritogenoside binds directly with the Nterminal amino acid of the peptide portion. In this paper, we * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "aduertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. present the complete structure of nephritogenoside along with its peculiar chemical features.
EXPERIMENTAL PROCEDURES
Preparation of Nephritogenoside-Rat glomerular basement membranes were prepared from perfused renal glomeruli by the method of Krakower and Greenspon (8) . The methods for the preparation of nephritogenoside were described previously (1) .
General Analyses-The amino acid composition was determined by high-performance liquid chromatography (HPLC)' with a fluorescence detector, after hydrolyzing the samples in 6 N HCl for 24 h at 110 'C in an evacuated sealed tube. A stainless-steel ISC-O7/S 1504 column (150 X 4 mm inner diameter) was used. The detector settings were excitation 350 nm and emission 450 nm for 0-phthalaldehyde (9) . Dansyl amino acids and dansyl-C1 were purchased from Seikagaku Kogyo Company, Tokyo. The HPLC units consisted of a Shimadzu Model LC-6A HPLC. A stainless-steel column (250 X 4 mm inner diameter) was packed with Develosil C 18 (Nomura Chemical Co., Seto, Japan). Excitation and emission wavelengths were 340 and 530 nm, respectively. Fraction 10 was submitted to NHz-terminal amino acid sequence analysis in the Applied Biosystems Model 470A sequenator (10). Nuclear Magnetic Resonance ('H, 13C NMR) Spectrometry-NMR spectroscopy of fraction 16 was performed on a JEOL GSX-400 MHz spectrometer. The sample was dissolved in 0.4 ml of DzO. Chemical shifts in both the proton and carbon spectra were assigned by reference to the shifts in D20 for internal 3-(trimethylsilyl)-l-propanesulfonic acid (6 = 0.00). 'H spectrum was taken with a pulse width of 8.2 ps and a computer memory of 16 K, I3C spectrum had a 1.5-s relaxation delay.
Ion-exchange Resin Treatment-Nephritogenoside (1 mg) was dissolved in 1 ml of water containing 2 g of Amberlite IRA-410 (OH-) and stirred for 10 h. The 1 N HCl eluate was lyophilized, yielding a white powder which was chromatographed on Sephadex G-100 (25 X 2.4 cm). The column effluent was monitored by absorbance at 210 nm with a UV detector, and the carbohydrate fraction was analyzed by the anthron method of 490 nm.
Carboxypeptidase Y Treatment-The carboxypeptidase Y was purchased from the Peptide Institute, Inc., Osaka, Japan. The nephritogenoside (1 mg) was dissolved in pH 6.5,0.05 M N-ethylmmpholine at a concentration of 1 mg/50 ml, and the solution was subsequently readjusted to pH 6.5. The N-ethylmorpholine solution (1 ml) of the carboxypeptidase Y (0.1 mg) was added, and the mixture was agitated gently at 37 "C for 48 h. At the end of the digestion period, the reaction mixture was taken to pH 6.0 and centrifuged to remove carboxypeptidase Y. The clear supernatant was then lyophilized. The adex G-100 (25 X 2.4 cm). The elution profile is shown in Fig. la . lyophilized compounds were chromatographed on a column of Seph-
The column effluent was monitored by the same methods as described above. The yields and the component ratios of each fraction are shown in Fig. lb. 
RESULTS AND DISCUSSION
In the course of taking off the protecting groups of the synthetic analogues of nephritogenoside, we have found that the amido linkage between glycosylamine and aspartic acid, carboxypeptidase Y at pH 6.5 (37 "C) for 2 days and then lyophilized.
The sample thus obtained was applied to a column of Sephadex G-100. AS shown in Fig. la , five peaks of both sugar and peptide (fractions 4, 7,9,11, and 16) were observed. The amino acid content of each fraction in 6 N HC1 hydrolysate is shown in Fig. l b . Fig. IC shows the cleavage position of each fraction. From the results obtained by the comparative studies on the amino acid contents of each peak (fractions 4, 7, 9, 11, and 16), the possibilities of two other binding types, i.e. binding at the 9th Glu and binding at the 10th Asp, were denied. When we also take 'H and "C NMR spectra of fraction 16 into consideration, it can be concluded that the trisaccharide chain and the peptide portion of nephritogenoside bind directly with Nterminal Asp.
glutamic acid, and/or glycine can be cleaved by ion-exchange resin (Amberlite IRA-410(0H-)) treatment (11) . This resin treatment was successfully applied to nephritogenoside.
After the cleavage by resin of the amido linkage between the carbohydrate and the peptide of nephritogenoside, the peptide portion was hydrolyzed with 6 N HCl for 24 h at 110 "C. There were 21 amino acid residues in all, and their composition coincided with that of nephritogenoside.
The N-terminal sequence analysis of the peptide portion was performed by the sequential Edman degradation method, in the presence of polybrene, using an Applied Biosystems Sequenator, model 470A. The sequence determined is as follows: Asp'-Pro-Leu-Phe-Gly6-Ile-Ala-Gly-Glu-Asp'o-GlyPro-Thr-Gly-Pro'6-Ser-Gly-Ile-Val-Gly20-Gln21. acid of the peptide portion by reverse-phase HPLC on Develosil C 18, using a linear gradient made from Tris-HC1 buffer (pH 7.75) and methanol (12) . The C-terminal amino acid of the peptide portion has been confirmed by carboxypeptidase Y (13) to be 1 mol of glutamine.
Considering the presence of N-terminal Asp, the 9th Glu and the loth Asp, the following three binding types can be proposed 1) binding at the N-terminal, 2) binding at the 9th Glu, and 3) binding at the 10th Asp. To further elucidate this problem, nephritogenoside was treated with carboxypeptidase Y at a pH of 6.5 (37 "C) for 2 days and then lyophilized. The sample thus obtained was applied to a column of Sephadex G-100. Sephadex G-100 was used instead of G-10 because nephritogenoside is an easily aggregated compound, and a column of Sephadex G-10 would not cause the separation. As shown in Fig. la , five peaks of both sugar and peptide (fractions 4, 7, 9, 11, and 16) were observed. The amino acid content of each fraction in 6 N HC1 hydrolysate was then examined.
As shown in Fig. lb , the amino acid content of fraction 4 was the same as that of the starting material. In fraction 7, Gly, Ile, Val, Gly, and Gln residues were reduced in comparison to the starting material. In fraction 9, Thr, Gly, Pro, and Ser residues were less than fraction 7. In fraction 11, ASP, Gly, and Pro residues were less than fraction 9. In fraction 16 + 33.4" (C = 0.014, HzO), Leu, Phe, Gly, Ile, Ala, Gly, and Glu residues were less than fraction 11. In this fraction we can find only Asp and Pro residues as amino acids.
The proton nuclear magnetic resonance ('H NMR) spec- (Fig. 2, a and b) . 'H and 13C NMR spectra were in accordance with those of the synthetic compound (Glc(al+ G(Glc(p1-G)Glc(al+ Asn-Pro)). Based on the observations described above, nephritogenoside is now established as a glycopeptide in which the trisaccharide chain is a-N-glycosidically linked to the peptide portion through the amido nitrogen of an N-terminal asparagine residue (Fig. 3) .
These results were supported by evidence that glomerulonephritis was induced in rats by a single footpad injection of synthetic analogues of nephritogenoside (14) , in which glucose is a-N-glycosidically linked to asparagine (Glc(al-6) Glc(p1-6)Glc(al+N)Asn) (6, 7, 15, 16) .
In the field of nucleoside type antibiotics, many N-glycosides have been reported (17) . However, in glycoproteins, almost all of the compounds reported until now have been those having 0-glycosidic linkage between the sugar portion and the amino acids (18) . As for N-glycosidic linkage, only N-acetylglucosaminylasparagine was known to exist (19) . In 1983, Wieland et al. (20) found an asparaginylglucose having N-glycosidic linkage between glucose and an asparagine from Halobacterium strain MI, but this linkage was found to be p-N-glycosidic. Thus, nephritogenoside is the first example, among natural compounds, of a carbohydrate-peptide linkage having direct a-N-glycosidic linkage between the trisaccharide and the amino acid residue (asparagine).
